Saturday, 24 August 2013

FDA Circular of Information for the Use of Human Blood and Blood Components

A new FDA guidance document has been issued "Circular of Information for the Use of Human Blood and Blood Components".

The circular provides specific labeling instructions for the administration and use of blood and blood components intended for transfusion. To view the document, see FDA.

Posted by Tim Sandle

Special offers